We think that SA- and SD-administrated mice exhibited a positive reaction in the gut by increasing the activation of immune cells, such as Th17 cells, with the increased production of IL-17 and IL-22 aggravating as well the phenotype of psoriasis-like dermatitis. The gene discussed is IL17A; the disease is psoriasis.